Completed PHASE3 INTERVENTIONAL 4-arm NCT01825109

Improving Rotavirus Vaccine Immune Response

Improving the Immune Response to Rotavirus Vaccine

Sponsor: Centers for Disease Control and Prevention

Interventions Rotavirus Vaccine & Breastfeeding

Updated 5 times since 2017 Last updated: Apr 4, 2013 Started: Jul 31, 2010 Primary completion: Apr 30, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01825109, this PHASE3 trial focuses on Healthy Infants and Mothers and remains completed. Sponsored by Centers for Disease Control and Prevention, it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centers for Disease Control and Prevention
European Centre for Disease Prevention and Control, SE-171, Stockholm
International Centre for Diarrhoeal Disease Research, Bangladesh
National Institutes of Health (NIH)
The Swedish Institute for Infectious Disease Control, SE-171 82 SOLNA

Data source: International Centre for Diarrhoeal Disease Research, Bangladesh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dhaka, Bangladesh